Institutional investors purchased a net $2.3 million shares of NVAX during the quarter ended June 2019 and now own 61.65% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 2.1 Million shares of Novavax Inc
SHAH CAPITAL MANAGEMENT, INC. Bought 1.2 Million shares of Novavax Inc
SSGA FUNDS MANAGEMENT, INC. Bought 576.8 Thousand shares of Novavax Inc